Table 1.
Clinicopathological characteristics of patients with biliary tract cancer or benign biliary disease and healthy volunteers
| Characteristics | BTC patients (n = 94) | BBD patients (n = 23) | HVs (n = 50) | ||
|---|---|---|---|---|---|
| Gender (men/women) | 56/38 | 12/11 | 37/13 | ||
| Age (years)a | 66 ± 9 | 56 ± 14 | 61 ± 9 | ||
| Disease type | Intrahepatic chorangiocarcinoma | 21 | Gallstone | 3 | |
| Biliary duct cancer | 48 | Cholecystitis | 8 | ||
| Gallbladder cancer | 14 | Adenomyomatosis | 1 | ||
| Ampulla of vater cancer | 11 | Gallbladder polyp | 2 | ||
| Cholangitis | 1 | ||||
| Choledocal cyst | 3 | ||||
| Malfusion of pancreaticobiliary duct | 1 | ||||
| Bile duct dysplasia | 1 | ||||
| Postoperative stenosis | 1 | ||||
| CA19‐9 (U/mL)a | 161 ± 605 | 12.1 ± 9.8 | 3 ± 5 | ||
| ≤37 | 60 | 23 | |||
| >37 | 34 | 0 | |||
| Maximum tumor size (cm)a | 3.2 ± 2.3 | ||||
| Tumor number: single/multiple | 91/3 | ||||
| T factor: T1/T2/T3/T4 | 13/22/49/10 | ||||
| Lymph node metastasis: negative/positive | 50/44 | ||||
| TNM staging: I/II/III/IV | 15/35/27/17 | ||||
| Curative/non‐curative resection | 69/25 | ||||
a
Data are mean ± standard deviation. CA19‐9, carbohydrate antigen 19‐9.